Merryn Talks Money: FOMO is Not an Investment Strategy (Podcast)

The episode focuses on a potential SpaceX IPO, asking how UK investors could access it, whether the valuation is justified, and how it may complicate passive investing. It also frames the deal as part of a broader wave of AI IPOs still to come, with implications for market structure and investor behavior. The piece is commentary rather than a concrete transaction update, so near-term market impact appears limited.

Analysis

The immediate winner is not the issuer so much as the entire private-markets distribution stack: banks, late-stage venture funds, secondary platforms, and any vehicle that can package scarcity into a tradable wrapper. A marquee float in a story-stock tape tends to pull forward demand from the same marginal buyer, which is a hidden tax on the rest of the AI complex as capital gets reallocated rather than newly created.

The second-order risk is benchmark contamination. When a high-beta, narrative-heavy listing enters indices, passive flows become more fragile because index funds must hold an asset whose free float, lockup path, and valuation elasticity are all less stable than the rest of the basket. That can create short-lived dislocations in both the new listing and the “closest substitutes” universe: listed private-credit, semis, cloud, and defense-tech names can trade off not on fundamentals but on relative scarcity of exposure.

The contrarian read is that the market may be underpricing how quickly the IPO window can become self-reinforcing. If the deal prices well and holds up for 4-8 weeks, it can loosen venture exit conditions and bring forward a queue of similarly priced AI listings, which is mildly bearish for quality dispersion because mediocre issuers get funded at better terms. Conversely, if it breaks on day 1 or in the first lockup-adjacent weeks, the signal will be harsher for late-stage private marks and could stall the whole AI issuance pipeline for 1-2 quarters.

Key Decisions for Investors

• Short a basket of near-substitute AI beneficiaries into the first 1-2 weeks post-pricing (e.g., NVDA/SMCI/CRWD/PLTR depending on beta mix) if the listing prints strong; the trade is on relative-flow exhaustion, not fundamentals, with a 3-6 week horizon.
• Use a pairs trade: long quality semis or AI infrastructure with durable FCF, short high-multiple, narrative-driven software names most likely to be treated as liquid proxies for the IPO theme; target 10-15% relative downside if issuance enthusiasm broadens.
• Buy downside on the new listing only after the first post-IPO volatility compression; the best entry is typically after 10-15 trading days when implied volatility decays but lockup overhang is still unpriced, offering asymmetric convexity.
• Overweight listed private-markets platforms and secondary liquidity providers for 1-3 months if IPO activity accelerates; they capture fee and spread upside from a reopening window, but trim fast if the first high-profile deal trades poorly.
• Set a trigger to de-risk AI beta baskets if the new issue weakens more than 20% from peak within the first month; that pattern usually shifts sentiment from scarcity premium to valuation scrutiny and can cascade across late-stage tech.